approval, it if can the not generic. how that's launch that's how launch. that, get we transferred we okay. brand yes. If to a yes, we is the you premise a a Usually With get happens, product is approval, But then that's being answer
You can launch the day.
get You approval.
satisfied. certain tentative to are got wait approval till things you if approval, you'll or have Now,
out exclusivity Do any first. have generic rights? other have wait to We company
done the have But the as filed We yet. gives of exclusivity FDA somebody satisfied else we required start head they of and FDA to anybody now, well. do a that us. of on somebody filed, not market. lot people We will as all testing days if have FDA by requirements. a have has don't the all we they're all know know and If beat that us don't then know know there's the that XXX to going If filed but they're
expect over this any Elite from Does product? lawsuits Purdue
Purdue It would difficult over suing be not this to anybody imagine product.
always It's place. the biggest Okay. product. They'll find their
sue That's doesn't going not hinder though. find to something the from to to Of for. us That be course, the, they're launching triumph, find unexpected.
a the see got You they point. have if to assess and valid risk
a and patent challenging winning manner. tests in positive in Does the It does Elite? effect OxyContin
a somebody has somebody else They in patent the invalidate themselves. for When industry. it it, don't they invalidate for everybody only invalidated and
can in without and test go some on when invalidated patents, restrictions us are patents file we on ahead no Purdue attributes. longer the these of challenged either valid their on So and these
So the everybody did positive did was challenge Elite an in it as effect in on on test they and have industry. else a one
Only Does the all are is they or irrelevant. The head start? fact of get in if, in satisfy FDA that first there to file requirements. XXX-day won court tests a case
sue all and your first out it. could of anything but don't have not invalidate of you somebody get you if application pending patent, you're going to their So to on a file,
get XXX knowledge yet. an are to that they to only file the days haven't So, of they my the to application if filed they best heard going and the I are first
about with filed in numbers ANDAs size pipeline, the FDA? the We that or any are are these comes. about IMS the expected make with products numbers, release the will The movers make what comes. a time of to we when General statement when will announced the market closest being definitely for the time when the a pipeline FDA? be pending these that IQIA press already IMS needle Are
category. cardiovascular discussed are in for Opioid in We a movers categories. needle opioid stimulus the have one largest the as in the of category foresee are and two don't recently the what All but products and Elite undisclosed the stimulus yet, does we're cardiovascular. opportunity. other Well,
and company there an as Adderall know really shows Does we how IR but not IR don't products of makes other these is and we Indian the evidence are the any Adderall But that going in instead bigger of will right all The now have three. and how that because big, undercut to least if we cheap these and everybody. answer our ER? outperforming two Elite be yes, than at ER API players many don't know
mark. say Whether the few to going to remains One, of anything and done to Are question be insufflation After I BE in for will this any year CRO and of one year. BE get expect we scientists products. regarding it's the QX studies quite a new the and this it do meeting a a needle positive calendar year? the few let's this results completed we We've with movers. and be tomorrow tomorrow, the pilot studies are and expected
factors submitted been that we run Have at a running We'll going like the we a on clinical beds been disclosed are whether of the site. several already determine in pilot I BE shareholders? it haven't to availability including that products question. or or if FDA year to to are any fall depending next and
it. it, not Okay. not did you are obviously If telling we we disclose about
open with time an you the going when So, the issue FDA. that submit the we question in couple minutes. up will speak is to to a tell of you except releases update that to ANDA press when comes, will I we door not We always and
shortages? FDA, DEA the the additional any unused future recent with and quota API about and DEA Adderall, conversations had Given letter has Adderall? on for quota FDA Elite
the the the with that conversations DEA, us and they approved, the a do but current to finished quota, more give get submit couple but not to we that API have with and do the product regularly, show show so process We on. and us do quota just months, hand mouth. and we the only some give in it's immediately go all of and them FDA in, We contracts back it, order us they quota test and time because ask give the for DEA the bring to quota they have them make sales it all order it,
year Elite granted for this quota additional any Does next? the anticipate being and
huge more if importantly, put of a small market us of business. course, us give We they'll as number quota one, they'll respectable a a number not And they out command company. have a portion the do two shortage. Of
the at not DEA said, does has in issuing liberal been release. with not work the that's FDA DEA and recent they are I granted There us, drug quota. I little shortage, as time. matters to boost guess quite. address output with They a are super urging us, does So, to press The operate presses but Adderall
Okay. comment Company's this it to to how will increase and on increase make impact the the Adderall Can the Elite output? easier Will DEA quota products? you Company's
asking they're have but has XX, of a statement made before us a give copies XX to wasn't hundred. to give quota, XX? it you kilos you of for it if back. were at need and you actually public. give gist issued Would to combined they And FDA and we like back volunteering need ask XX. that the not that a received you everybody DEA it quota that the asking It extra you quota other only XXX you was have really, them Did extra it say, hey, to you you The
If it. you it, haven't read read And it you read it, please if carefully. treat
the FDA the and the starting the work to FDA The and try FDA but the to then does because situation? DEA impact shortage with is manage
to an at a easy. worth It's couple but really, lot done has easy It job of We've been a to-date, not for not great us quota. a managing process. it months, requires it of get
the mention beginning Partnership, Adderall Can January I also and going Prasco I agreement distribute you XXX% Xst was as ER to alone thought expand Prasco our date CC commercial Burel with after sales. Epic. that? the agreement on first or during and the and Burel ended of new Lannett we Elite the
Prasco I everything. on motto anything very we we deal generic of and it never asked yes. sales the us My and who XXX% Prasco/Burel we It'll are is you force excellent. effect said, instead If Elite and and it. the as they is into materialize with simple. them authorized do we're do if money, not know. supply to go X, the will January generic for Burel Xst XXXX, with would open-minded makes for go authorized The of January
and materialize more. this very that that not us backs hysteric there charge the that the sales in backs becomes income protect their consuming and always event that own in see contract working multiple on because and and discuss a also easier and of an the of about I label, transaction Prasco complicated it's rebates. no Company financials. But financial we'll other all This Once is and am having rebates amount and Burel charge sources capital and the doing points helps and nice into material by about are it to
the with decided from don't auditor. from. already came How temporary where I is [indiscernible], to search using CFO consultants CFO accounting contracts the operate the in this has permanent interim? new you operation the Corporate Are know going? and
and by qualified We this us frankly as the in has internal consultants have finances. have with we hammered business the place And CFO. fact while two having has CFOs a before been and controls is have we helping activity personnel a that no time necessary identify the and In do way XX-K Q working permanent last entire helped put the the CFO. us
So, when doing the help an lot have we well. make of a find a very we'll In we permanent and announcement. CFO, we're meantime,
the I the time, gave the In without actually stock up. that to addition went presentation fact last CFO, this a
So goes. for may awhile. We'll I see hire that not how one
max XXxX. We to the make anymore still Alright, in are to out about point run current what facility, expected shift. we when third in it enough the it's time have and that production, to second cannot really there, sales capacity go land it the in difficult at and but really is
where the the are So, third before departments solution all and a about to point I or to we that. time definitely get I that last weekends, having go thinking in shift as mentioned shift to for we second
new and in shifts. packaging got our in shifts we way created people come stay were nearing at we extended in do, go too Are morning early that the late. need the running to any much We ahead to for we for for facility? example be and be to Anytime accommodate
we as shifts thing thing caught two in to as lab, the people till manufacturing. up. the the we then afternoon do Same ran in the and same staggered we morning So, well
it Couple the and lady, purposefully not constantly first continue I years to minimum via the of they entertain so, put I I price some enough a intentionally that address, naysayers entertaining. bare gossip and be I say the have questions could press low shares the allege that board, out dilution. don't to the releases Alright, Says at person, but that know. recommend going salary accumulating over first, apologize, them message Diane from gentleman, because does was were I'll been
very private not believe at clear, a do serious ultimately Company, take personally be conspiracy over price. To I this. theories, take To low it the
a designed is it to Please think stock. refuting I harm smear the consider publicly. this
shares so assets get done or them done interest value be selling not addressed I private. would've to else have I stated much no over to would Company, taking want If before, more. that this First for profitable and time to before have have it the Company done I've or Elite take long what I I in via ago I have the I something and
so, already they keep they to but But what Okay, let's settled this over and believes don't and same when said lies it. people I've don't listen, listen, again till you over step-by-step. take issue, the want somebody repeating
we minimum First, regarding bare the press moment press about releases issue releases, think and purposefully that take a that.
have When revenues about all year in companies, we we've great been than moving great Company's before. every releases, and we with contracts stuff to the more press issue, past achievements that the profitability and creating year years five other profound of the financials more and done profit the when
of even When this into joke. press you somebody a all it'll stupid, do can product Mickey releases lead doesn't thinking oh, and wants stock Do through move at press in press a No, look about make and making releases we're we that. anything? they to going superficial that When or us invest is it think, Mouse the the statement all to see releases, are the like, move. all filing and
change no So yes, taken at issue that four anytime with do we're over that, a times releases for our interest event, relevant. have other I that are not financials issue the than the a addressed in personally. is material the year practices, to there this already we our okay. Company. doing going We only I press have least and
I Company few and that, with I've doing before, interest like have Now, and that. fine before buy bought private, will, buy months it. But old for fine. if me few stated personally, I my are the I'm to activist months have back Elite, epic, take in private, to zero human a company a wanted Elite, they which to that's a wanted company If
is long. really Second question
on with price, gist read the do the over have greatly and into the frustrated the So says, improved the stock stock translated I'm years, business a do investors has honestly it. on Company many analyzing not of I'll are Company success. but price stock that fundamentals want well. goes person the Since both The and very about and I not, the but to
to is and million to One And XX The gist a a X A is, XX and things. first even anywhere two all from asking Elite million of million commentary stock in be that's that ASAP million XXX,XXX dollars salaries the page to second, full paying one. plan. the currently shares. cash million am XX consider buyback would consider I
the We will and buybacks of all date. about future that talk at
shares outstanding XX to going stockholders. on Investing the anything plus could the going and on not $X Amphetamine that when huge or a multiple And or you $X Company. million one million million ER do it's IR that have get us take away to billion the can trials bring clinical spent shares impact is to have Company be to an
to in issued going do to one, that the is first that this Elite ASAP. but as decree salaries consider I cash we're paying that. So,, immediately second your to all ask inquiry hereby the
you have do For voted two week. reasons, and already the asked two we number because that that Board one, because number last really
So board then about a with in it that. Company for it Company and the it around doing it But money. for turn it. couldn't afford afford to Well, us because take hypocritical approved loan the ago money and the the and caveat cash Board we is example, approved actually year me, can as the
same we're has do thinking. been thinking the the even So we though along line that's board why it didn't
pay cash. sense. loan in everybody you you clinical It then other any there less and cash make less in to money if side, we're and cash, us didn't is also you we in But to Let's money. start do have we asking trials then paying paying the
before So about one, talked one meeting, that. in this last the we meeting annual last
said they thing. the same In this one
and on. what light You still this doing consider work to to that's green we're have going a
we're to stock So or this both everybody matter work it on table, in viable. buyback your One, a are is you whether and ideas not. the there on paying can is cash going of afford second the but
Board loaned our profitable and to program after us where for buyback trials, we the all a will you loans as be I've know, the into of be time there'll but that When Company spend money, as lot make a Elite buying pay the paid clinical means enough be split within an money one a supporting will the And then of its Directors spend for great sense and of us is our money Company money to members on can it'll it on loan well. that R&D back also Elite stocks. live
forward said, the you to on that to and Matthews in looking With talking day. Thank second you November have everybody reporting quarter's and great being results. a
